HRX gene rearrangement in acute lymphoblastic leukemia after adjuvant chemotherapy of breast cancer [letter; comment]Yoshinao Kobayashi, S Asano, Jianli Yang et al.|Blood|1993Cited by 34
509 A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low dose cyclophosphamide for patients with advanced solid tumorsYasuhiro Hijikata, Hiroaki Ogata, Mutsunori Murahashi et al.|European Journal of Cancer|2015Cited by 0